| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
|
27,175 |
22,124 |
$1.42M |
| 99202 |
|
6,270 |
5,010 |
$308K |
| 99203 |
|
2,853 |
2,344 |
$187K |
| 99214 |
|
1,340 |
1,118 |
$99K |
| 87804 |
|
13,745 |
6,270 |
$56K |
| 87426 |
|
4,358 |
3,498 |
$51K |
| 87880 |
|
7,131 |
5,887 |
$25K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
421 |
399 |
$25K |
| 99212 |
|
593 |
545 |
$21K |
| 99211 |
|
700 |
583 |
$20K |
| 96372 |
|
2,120 |
1,764 |
$11K |
| 87807 |
|
1,513 |
1,158 |
$6K |
| 81025 |
|
3,946 |
2,978 |
$6K |
| 71046 |
|
875 |
741 |
$5K |
| 81003 |
|
4,753 |
3,654 |
$3K |
| 86308 |
|
287 |
200 |
$423.33 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
501 |
398 |
$380.03 |
| 94640 |
|
183 |
171 |
$291.26 |
| 87210 |
|
145 |
117 |
$166.94 |
| 99000 |
|
1,560 |
1,340 |
$159.77 |
| 87490 |
|
126 |
112 |
$110.00 |
| 87086 |
|
390 |
365 |
$61.75 |
| 87635 |
|
273 |
264 |
$51.33 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
46 |
43 |
$41.95 |
| 81002 |
|
33 |
25 |
$35.62 |
| 82962 |
|
44 |
39 |
$24.83 |
| 87591 |
|
164 |
154 |
$24.00 |
| 99072 |
|
605 |
521 |
$16.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
32 |
29 |
$10.57 |
| 87070 |
|
41 |
40 |
$4.20 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
78 |
77 |
$0.00 |